BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11477570)

  • 1. Binding of a SART3 tumor-rejection antigen to a pre-mRNA splicing factor RNPS1: a possible regulation of splicing by a complex formation.
    Harada K; Yamada A; Yang D; Itoh K; Shichijo S
    Int J Cancer; 2001 Sep; 93(5):623-8. PubMed ID: 11477570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNPS1 is modulated by ubiquitin-specific protease 4.
    Kwon SK; Kim EH; Baek KH
    FEBS Lett; 2017 Jan; 591(2):369-381. PubMed ID: 27990632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human RNPS1 and its associated factors: a versatile alternative pre-mRNA splicing regulator in vivo.
    Sakashita E; Tatsumi S; Werner D; Endo H; Mayeda A
    Mol Cell Biol; 2004 Feb; 24(3):1174-87. PubMed ID: 14729963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of human RNPS1: a general activator of pre-mRNA splicing.
    Mayeda A; Badolato J; Kobayashi R; Zhang MQ; Gardiner EM; Krainer AR
    EMBO J; 1999 Aug; 18(16):4560-70. PubMed ID: 10449421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of pre-mRNA splicing by human RNPS1 is regulated by CK2 phosphorylation.
    Trembley JH; Tatsumi S; Sakashita E; Loyer P; Slaughter CA; Suzuki H; Endo H; Kidd VJ; Mayeda A
    Mol Cell Biol; 2005 Feb; 25(4):1446-57. PubMed ID: 15684395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splicing activator RNPS1 suppresses errors in pre-mRNA splicing: A key factor for mRNA quality control.
    Fukumura K; Inoue K; Mayeda A
    Biochem Biophys Res Commun; 2018 Feb; 496(3):921-926. PubMed ID: 29366779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of alternative pre-mRNA splicing in vivo by pinin.
    Wang P; Lou PJ; Leu S; Ouyang P
    Biochem Biophys Res Commun; 2002 Jun; 294(2):448-55. PubMed ID: 12051732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear Pnn/DRS protein binds to spliced mRNPs and participates in mRNA processing and export via interaction with RNPS1.
    Li C; Lin RI; Lai MC; Ouyang P; Tarn WY
    Mol Cell Biol; 2003 Oct; 23(20):7363-76. PubMed ID: 14517304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exon junction complex-associated multi-adapter RNPS1 nucleates splicing regulatory complexes to maintain transcriptome surveillance.
    Schlautmann LP; Lackmann JW; Altmüller J; Dieterich C; Boehm V; Gehring NH
    Nucleic Acids Res; 2022 Jun; 50(10):5899-5918. PubMed ID: 35640609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
    Dauksaite V; Akusjärvi G
    Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning, expression and generation of a polyclonal antibody specific for RNPS1.
    Deka B; Singh KK
    Mol Biol Rep; 2022 Sep; 49(9):9095-9100. PubMed ID: 35939184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Communication of the position of exon-exon junctions to the mRNA surveillance machinery by the protein RNPS1.
    Lykke-Andersen J; Shu MD; Steitz JA
    Science; 2001 Sep; 293(5536):1836-9. PubMed ID: 11546874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNPS1 functions as an oncogenic splicing factor in cervical cancer cells.
    Deka B; Chandra P; Yadav P; Rehman A; Kumari S; Kunnumakkara AB; Singh KK
    IUBMB Life; 2023 Jun; 75(6):514-529. PubMed ID: 36300671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exon Junction Complexes Suppress Spurious Splice Sites to Safeguard Transcriptome Integrity.
    Boehm V; Britto-Borges T; Steckelberg AL; Singh KK; Gerbracht JV; Gueney E; Blazquez L; Altmüller J; Dieterich C; Gehring NH
    Mol Cell; 2018 Nov; 72(3):482-495.e7. PubMed ID: 30388410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tumor-rejection antigens in gynecologic cancers.
    Tanaka S; Tsuda N; Kawano K; Sakamoto M; Nishida T; Hashimoto T; Shichijo S; Kamura T; Itoh K
    Jpn J Cancer Res; 2000 Nov; 91(11):1177-84. PubMed ID: 11092984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocytes by its peptides.
    Murayama K; Kobayashi T; Imaizumi T; Matsunaga K; Kuramoto T; Shigemori M; Shichijo S; Itoh K
    J Immunother; 2000; 23(5):511-8. PubMed ID: 11001544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of alternative 3' splice site selection by constitutive splicing factors.
    Lin CH; Patton JG
    RNA; 1995 May; 1(3):234-45. PubMed ID: 7489496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The arginine and serine-rich domains of Acinus modulate splicing.
    Deka B; Singh K
    Cell Biol Int; 2019 Aug; 43(8):954-959. PubMed ID: 31070279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart.
    Ashiya M; Grabowski PJ
    RNA; 1997 Sep; 3(9):996-1015. PubMed ID: 9292499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intron enhancer recognized by splicing factors activates polyadenylation.
    Lou H; Gagel RF; Berget SM
    Genes Dev; 1996 Jan; 10(2):208-19. PubMed ID: 8566754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.